Author Response to Comment on: “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”

Ammar Abdulrahman Jairoun; Sabaa Saleh Al-Hemyari; Moyad Shahwan; Tariq Al-Qirim; Monzer Shahwan

doi:10.1177/11795514241260240

Author Response to Comment on: “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”

Ammar Abdulrahman Jairoun
, Sabaa Saleh Al-Hemyari
, Moyad Shahwan
, Tariq Al-Qirim
, Monzer Shahwan

College of Pharmacy and Health Sciences

Universiti Sains Malaysia
Dubai Municipality
Emirates Health Services
Al-Zaytoonah University of Jordan
AL-Swity Center for Dermatology and Chronic Diseases

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Clinical Medicine Insights: Endocrinology and Diabetes
Volume	17
DOIs	https://doi.org/10.1177/11795514241260240
State	Published - 1 Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1177/11795514241260240

Cite this

@article{94148994f8bf477d8bffd355c9a36b62,

title = "Author Response to Comment on: “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”",

author = "Jairoun, \{Ammar Abdulrahman\} and Al-Hemyari, \{Sabaa Saleh\} and Moyad Shahwan and Tariq Al-Qirim and Monzer Shahwan",

year = "2024",

month = jan,

day = "1",

doi = "10.1177/11795514241260240",

language = "English",

volume = "17",

journal = "Clinical Medicine Insights: Endocrinology and Diabetes",

issn = "1179-5514",

publisher = "SAGE Publications Ltd",

}

Author Response to Comment on: “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”. / Jairoun, Ammar Abdulrahman; Al-Hemyari, Sabaa Saleh; Shahwan, Moyad et al.
In: Clinical Medicine Insights: Endocrinology and Diabetes, Vol. 17, 01.01.2024.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Author Response to Comment on

T2 - “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”

AU - Jairoun, Ammar Abdulrahman

AU - Al-Hemyari, Sabaa Saleh

AU - Shahwan, Moyad

AU - Al-Qirim, Tariq

AU - Shahwan, Monzer

PY - 2024/1/1

Y1 - 2024/1/1

UR - https://www.scopus.com/pages/publications/85196150839

U2 - 10.1177/11795514241260240

DO - 10.1177/11795514241260240

M3 - Letter

AN - SCOPUS:85196150839

SN - 1179-5514

VL - 17

JO - Clinical Medicine Insights: Endocrinology and Diabetes

JF - Clinical Medicine Insights: Endocrinology and Diabetes

ER -

Author Response to Comment on: “Benefit–Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study”

UN SDGs

Access to Document

Other files and links

Cite this